Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0001852950-22-000003
Filing Date
2022-11-22
Accepted
2022-11-22 16:20:17
Documents
1
Effectiveness Date
2022-11-22
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 10094
  Complete submission text file 0001852950-22-000003.txt   11157
Mailing Address 11099 NORTH TORREY PINES ROAD, STE. 290 LA JOLLA CA 92037
Business Address 11099 NORTH TORREY PINES ROAD, STE. 290 LA JOLLA CA 92037 858-348-2180
Enlaza Therapeutics, Inc. (Filer) CIK: 0001852950 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D/A | Act: 33 | File No.: 021-393460 | Film No.: 221410646